Seagen to host virtual r&d day on november 16, 2020

Bothell, wash.--(business wire)--seagen inc. (nasdaq: sgen) announced today that it will host a virtual r&d day for investors and analysts on monday, november 16, 2020 beginning at 10:00 a.m. eastern time. the program will include a presentation by members of seagen leadership on the broad clinical development of the company's marketed products, adcetris® (brentuximab vedotin), padcev® (enfortumab vedotin-ejfv) and tukysa® (tucatinib), and its deep pipeline of innovative therapies for cance
SGEN Ratings Summary
SGEN Quant Ranking